Skip to main content

MANTLE CELL LYMPHOMA

Tracking # 20-1057838

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

MANTLE CELL LYMPHOMA (MCL) IS A RARE SUBTYPE OF B-CELL NON-HODGKIN LYMPHOMAS (NHLS) USUALLY IDENTIFIED BY A TRANSLOCATION OF THE CCND1 GENE. THE VARIETY OF MORPHOLOGIC VARIANTS MAY MAKE THIS A CHALLENGING DIAGNOSIS, ALTHOUGH MOST CASES ARE UNCOMPLICATED. IT TYPICALLY FOLLOWS AN AGGRESSIVE CLINICAL COURSE, ALTHOUGH AN INDOLENT LEUKEMIA VARIANT HAS BEEN DESCRIBED. THIS ACTIVITY ILLUSTRATES THE EVALUATION AND TREATMENT FOR MANTLE CELL LYMPHOMA AND REVIEWS THE ROLE OF THE INTERPROFESSIONAL TEAM AND NEW MANAGEMENT STRATEGIES IN MANAGING PATIENTS WITH THIS CONDITION.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I